Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin
- 1 February 1997
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 75 (3), 417-422
- https://doi.org/10.1038/bjc.1997.68
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Paclitaxel (Taxol) induces cumulative mild neurotoxicityEuropean Journal Of Cancer, 1994
- Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials groupEuropean Journal Of Cancer, 1994
- Activity of docetaxel (Taxotere) in small cell lung cancerEuropean Journal Of Cancer, 1994
- Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studiesAnnals of Neurology, 1994
- The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)Cancer Treatment Reviews, 1993
- Nerve growth factor prevents experimental cisplatin neuropathyAnnals of Neurology, 1992
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation.Journal of Neurology, Neurosurgery & Psychiatry, 1979